GLOBAL Clinical Study (GLOBAL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01738828|
Recruitment Status : Unknown
Verified February 2016 by Global Genomics Group, LLC.
Recruitment status was: Active, not recruiting
First Posted : November 30, 2012
Last Update Posted : February 9, 2016
The GLOBAL study is an international multi-center, prospective study designed to enroll up to 10,000 consecutive eligible subjects who are clinically referred for coronary CT angiography for assessment of suspected coronary artery disease (CAD).
The purpose of the study is to perform extensive biomarker analysis of atherosclerosis in patients phenotyped using advanced imaging modalities of atherosclerosis.
|Condition or disease|
|Coronary Artery Disease|
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Observational Model:||Case Control|
|Official Title:||Genetic Loci and the Burden of Atherosclerotic Lesions|
|Study Start Date :||December 2012|
|Actual Primary Completion Date :||May 2014|
|Estimated Study Completion Date :||December 2016|
|Subjects with CAD|
|Subjects without CAD|
- Genome-Wide Association [ Time Frame: Baseline ]The primary analysis will be a genome-wide association analysis, to determine candidate genes and markers underlying coronary artery disease.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01738828
|Study Director:||Szilard Voros, MD||Global Genomics Group, LLC|